AngioDynamics (FRA:UG2) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UG2 AngioDynamics Inc FRA:UG2
59 GF Score
Price €13.60
GF Value €8.21
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is AngioDynamics 5-Year Yield-on-Cost %?

AngioDynamics FRA:UG2 59 5-Year Yield-on-Cost % is 0.00 as of Aug. 15, 2026. GuruFocus rates FRA:UG2 with a GF Score™ of 59/100 and a GF Value™ of €8.21 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 316 Medical Devices & Instruments companies, AngioDynamics ranks worse than 316455.38% on this metric.

AngioDynamics's yield on cost for the quarter that ended in May. 2026 was 0.00.


The historical rank and industry rank for AngioDynamics's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:UG2's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.36
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

AngioDynamics  (FRA:UG2) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


AngioDynamics 5-Year Yield-on-Cost % Related Terms


FRA:UG2 vs NNNN, OSUR, SMTI: 5-Year Yield-on-Cost % Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where AngioDynamics's 5-Year Yield-on-Cost % falls into.


FRA:UG2
59GF Score
AngioDynamics Inc FRA:UG2
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AngioDynamics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of AngioDynamics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
AngioDynamics (FRA:UG2) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on AngioDynamics and its competitors. According to the industry distribution chart, AngioDynamics ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is AngioDynamics' 5-Year Yield-on-Cost % too high?
AngioDynamics' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, AngioDynamics ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, AngioDynamics has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AngioDynamics' 5-Year Yield-on-Cost % compare to NNNN and OSUR?
According to the Medical Devices & Instruments industry distribution chart, AngioDynamics ranks #999999 out of 316 companies for 5-Year Yield-on-Cost %. This places AngioDynamics in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.36, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on AngioDynamics and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AngioDynamics's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AngioDynamics stock overvalued right now?
Based on GuruFocus' analysis, AngioDynamics (FRA:UG2) is currently considered Significantly Overvalued. The stock's GF Value™ is €8.21, compared to a current price of €13.60 — trading 65.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. AngioDynamics' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For AngioDynamics (FRA:UG2), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (FRA:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €13.60 is trading 65.7% above its estimated GF Value™ of €8.21. GuruFocus considers AngioDynamics to be Significantly Overvalued.

Key valuation signals for FRA:UG2:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: €8.21 vs. price of €13.60 (65.7% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the FRA:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AngioDynamics Business Description

Other Exchanges ANGO:USA
Address 14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
59GF Score

Get the complete analysis for FRA:UG2

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.60
Price
€8.21
GF Value